Literature DB >> 1384504

Anti-human immunodeficiency virus effects of cationic metalloporphyrin-ellipticine complexes.

L Ding1, J Balzarini, D Schols, B Meunier, E de Clercq.   

Abstract

A series of cationic metalloporphyrin-ellipticine complexes were found to inhibit the cytopathicity of human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus in MT-4 cells at concentrations ranging from 1.4 to 17 micrograms/mL, i.e. at a concentration that was 2.5-30-fold below the cytotoxicity threshold. These compounds were also found to inhibit syncytium formation between persistently HIV-1-infected HUT-78 and uninfected Molt/4 cells, to interfere with HIV-1 binding to the cells, and to suppress HIV-1-associated reverse transcriptase activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1384504     DOI: 10.1016/0006-2952(92)90486-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  6 in total

1.  The role of carboxymethyl substituents in the interaction of tetracationic porphyrins with DNA.

Authors:  Oxana A Kovaleva; Vladimir B Tsvetkov; Anna K Shchyolkina; Olga F Borisova; Valentina A Ol'shevskaya; Anton V Makarenkov; Alexander S Semeikin; Alexander A Shtil; Dmitry N Kaluzhny
Journal:  Eur Biophys J       Date:  2012-08-19       Impact factor: 1.733

2.  In vitro antimalarial activity of metalloporphyrins against Plasmodium falciparum.

Authors:  Khurshida Begum; Hye-Sook Kim; Veena Kumar; Igor Stojiljkovic; Yusuke Wataya
Journal:  Parasitol Res       Date:  2003-03-12       Impact factor: 2.289

3.  Preferential DNA photocleavage potency of Zn(II) over Ni(II) derivatives of carboxymethyl tetracationic porphyrin: the role of the mode of binding to DNA.

Authors:  Oxana A Kovaleva; Vladimir B Tsvetkov; Olga K Mamaeva; Valentina A Ol'shevskaya; Anton V Makarenkov; Lyubov G Dezhenkova; Alexander S Semeikin; Olga F Borisova; Alexander A Shtil; Anna K Shchyolkina; Dmitry N Kaluzhny
Journal:  Eur Biophys J       Date:  2014-08-28       Impact factor: 1.733

4.  Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranostics.

Authors:  Leanne B Josefsen; Ross W Boyle
Journal:  Theranostics       Date:  2012-10-04       Impact factor: 11.556

5.  The phthalocyanine prototype derivative Alcian Blue is the first synthetic agent with selective anti-human immunodeficiency virus activity due to its gp120 glycan-binding potential.

Authors:  Katrien O François; Christophe Pannecouque; Joeri Auwerx; Virginia Lozano; Maria-Jésus Pérez-Pérez; Dominique Schols; Jan Balzarini
Journal:  Antimicrob Agents Chemother       Date:  2009-08-31       Impact factor: 5.191

6.  Photodynamic therapy and the development of metal-based photosensitisers.

Authors:  Leanne B Josefsen; Ross W Boyle
Journal:  Met Based Drugs       Date:  2008
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.